mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.3 |
mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
0.12 |
0.3 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |